Target intelligence / Profile preview

Oral microbiota producing volatile sulfur compounds (VSC-producing oral microbiota)

Target
VSC-producing oral microbiota
Molecular classification
Microbiota, Bacterial community, Other
01

Overview

The oral microbiota producing volatile sulfur compounds (VSCs) consists of a diverse group of predominantly anaerobic Gram-negative bacteria that reside on the tongue dorsum and within periodontal pockets. These microorganisms, including species such as Porphyromonas gingivalis, Treponema denticola, and Fusobacterium nucleatum, utilize proteolytic enzymes to degrade sulfur-containing amino acids like cysteine and methionine into malodorous gases, primarily hydrogen sulfide and methyl mercaptan (PubMed: 24571068, 16530701). These VSCs are the primary etiological agents of intra-oral halitosis and have been implicated in the pathogenesis of periodontal disease by increasing the permeability of the oral mucosa and promoting pro-inflammatory cytokine release (PubMed: 15752094). Therapeutic strategies targeting this microbiota include the use of broad-spectrum antimicrobials like chlorhexidine to reduce bacterial load, zinc salts to chemically neutralize VSCs, and probiotics to restore a non-malodorous microbial balance (PubMed: 21287871). While effective for symptom management, long-term use of certain chemical agents can lead to side effects such as tooth staining or shifts in the natural oral flora.

Other names
Halitosis-associated microbiotaOral malodor-associated bacteriaSulfur-producing oral bacteriaAnaerobic oral floraVSC-producing bacteria
02

Mechanism of action

Antimicrobial disruption of bacterial cell membranes, inhibition of thiol-containing enzymes (e.g., L-methionine γ-lyase), chemical neutralization and precipitation of sulfur gases, and competitive exclusion by probiotic strains.

03

Biological functions

ProteolysisAmino acid metabolismBiofilm formationAnaerobic respirationSulfur metabolism
04

Disease associations

HalitosisPeriodontitisGingivitisInfection
05

Safety considerations

Oral dysbiosisExtrinsic tooth stainingTaste disturbance (dysgeusia)Mucosal irritationDevelopment of antimicrobial resistance
06

Interacting drugs

Chlorhexidine

7 more in the full profile.

07

Biomarkers

Hydrogen sulfide concentrationMethyl mercaptan concentrationDimethyl sulfide concentrationBANA (Benzoyl-DL-arginine-naphthylamide) testOrganoleptic score

Beyond the preview

Go deeper on Oral microbiota producing volatile sulfur compounds (VSC-producing oral microbiota).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral microbiota producing volatile sulfur compounds (VSC-producing oral microbiota).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call